Loading organizations...
Novus Biologicals provides essential, high-quality antibodies, proteins, and assay kits for the global life science community. The company delivers validated tools for applications including ELISA, flow cytometry, and Western blotting. These products enable researchers to investigate biological pathways and disease states across fields like cancer, immunology, and neuroscience, emphasizing reproducible results.
Karen Padgett founded Novus Biologicals in 1996, observing a market need for specialized research reagents. Her insight led to licensing, producing, and distributing critical antibodies for emerging scientific fields. This core objective empowered researchers by supporting investigations into complex biological systems and driving progress in biotechnology.
Serving academic, government, and pharmaceutical researchers worldwide, its products are vital for scientific discovery and therapeutic development. Novus Biologicals' vision is to facilitate groundbreaking research via its validated reagents, directly advancing understanding of biological processes and disease mechanisms. It operates today as a key brand under Bio-Techne.
